Clinical Trials Browser

Phase 1 × TPI-287 × Clear all

NCT00867568 2024-08-06

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

Phase 1 Completed

18 enrolled 12 charts

Medulloblastoma, Neuroblastoma, Recurrence

NCT00113724 2009-06-04

Study of TPI 287 in Patients With Advanced Malignancies

Phase 1 Completed

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms

NCT00256191 2007-10-15

Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies

Phase 1 Completed

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms